Atlas Trials

Positive Surgical Margins Rate and EGFR Family Members Expression in Prostate Cancer Treated With Bicalutamide

Clinical trial NCT00421694 · COMPLETED

Trial details

NCT number
NCT00421694
Sponsor
University of L'Aquila
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Enrollment
119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.